Oyster Point
Acquired
- Headquarters
- USA, New Jersey
- Employees
- 201–500
- Founded
- 2015
- Business Model
- B2B
- Website
- oysterpointrx.com
- Total Funding
- $115.0M
- Last Round
- $93.0M Series BFeb 2019
About
Oyster Point is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account